Diligence memo · auto-generated · as of July 2, 2026

Rocket Health

Rocket Health looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Rocket Health operates in Healthtech, based in Uganda, Africa. Uganda’s Rocket Health, a telemedicine and last-mile healthcare provider, has closed a US$5 million Series A funding round to accelerate its technology roadmap and geographical expansion to the different regions of Uganda and into Kenya.

Sub-sector tags: healthtech.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Rocket Health has raised $5.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $5.0M on 2022-03-07.

Most recent recorded round closed around 2022-03-07.

Valuation (modeled)modeled

Provath models Rocket Health at approximately $60M (range $6.4M–$221M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.44× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era. Within the normal band (144% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 4.3 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 57% of Healthtech peers (2138 compared).

Modeled value ranks above 66% of those peers.

Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.